Gastric bypass showdown: which surgery cures diabetes best?

NCT ID NCT03821636

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares two versions of Roux-en-Y gastric bypass surgery to see which one is better at putting type 2 diabetes into remission in severely obese patients. The trial will enroll 396 people with a BMI of 35 or higher and type 2 diabetes. Participants will be randomly assigned to receive either a long alimentary limb or a long biliary limb bypass, and researchers will measure diabetes remission rates along with weight loss and complications.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Roux-en-Y gastric bypass surgery (two variants: long alimentary limb or long biliary limb)
What this could lead to
If successful, this could show that a specific type of gastric bypass surgery is more effective at putting type 2 diabetes into remission for severely obese patients.
What could go wrong
This is a surgical trial with inherent risks like infection or bowel obstruction. The results may not apply to all patients, and diabetes remission may not be permanent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 IN OBESE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ch Boulogne-Sur-Me

    RECRUITING

    Boulogne-sur-Mer, 62321, France

  • Ch de Valenciennes

    RECRUITING

    Valenciennes, France

  • Chu Amiens Picardie

    RECRUITING

    Amiens, France

  • Hop Claude Huriez Chu Lille

    RECRUITING

    Lille, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.